A detailed history of Aqr Capital Management LLC transactions in Cerus Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 61,373 shares of CERS stock, worth $95,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,373
Previous 215,901 71.57%
Holding current value
$95,741
Previous $379,000 72.03%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $262,697 - $369,321
-154,528 Reduced 71.57%
61,373 $106,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $316,081 - $398,028
195,112 Added 938.53%
215,901 $379,000
Q1 2024

May 15, 2024

SELL
$1.66 - $2.42 $1,455 - $2,122
-877 Reduced 4.05%
20,789 $39,000
Q4 2023

Feb 14, 2024

SELL
$1.25 - $2.35 $372,486 - $700,274
-297,989 Reduced 93.22%
21,666 $46,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.07 $285,360 - $584,036
190,240 Added 147.0%
319,655 $517,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $30,551 - $49,497
17,068 Added 15.19%
129,415 $318,000
Q1 2023

May 15, 2023

BUY
$2.65 - $3.81 $75,260 - $108,204
28,400 Added 33.83%
112,347 $333,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $18,150 - $22,661
-5,370 Reduced 6.01%
83,947 $306,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $208,636 - $354,621
60,827 Added 213.5%
89,317 $322,000
Q2 2022

Aug 15, 2022

SELL
$4.41 - $5.69 $77,527 - $100,030
-17,580 Reduced 38.16%
28,490 $151,000
Q1 2022

May 16, 2022

BUY
$4.81 - $6.99 $221,596 - $322,029
46,070 New
46,070 $253,000
Q2 2021

Aug 16, 2021

SELL
$5.35 - $6.35 $114,602 - $136,023
-21,421 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.68 - $7.87 $32,745 - $45,370
5,765 Added 36.82%
21,421 $129,000
Q3 2020

Nov 16, 2020

BUY
$5.78 - $7.47 $90,491 - $116,950
15,656 New
15,656 $98,000
Q2 2020

Aug 17, 2020

SELL
$4.5 - $7.02 $82,737 - $129,069
-18,386 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $152,978 - $190,435
-31,477 Reduced 63.13%
18,386 $95,000
Q2 2019

Aug 14, 2019

SELL
$4.51 - $6.6 $151,260 - $221,357
-33,539 Reduced 40.21%
49,863 $280,000
Q1 2019

May 14, 2019

SELL
$5.16 - $6.85 $937,866 - $1.25 Million
-181,757 Reduced 68.55%
83,402 $520,000
Q4 2018

Feb 14, 2019

SELL
$4.89 - $7.16 $1.83 Million - $2.68 Million
-374,646 Reduced 58.56%
265,159 $1.34 Million
Q3 2018

Nov 15, 2018

BUY
$6.89 - $7.78 $2.5 Million - $2.82 Million
362,504 Added 130.73%
639,805 $4.61 Million
Q2 2018

Aug 14, 2018

BUY
$5.19 - $7.25 $1.44 Million - $2.01 Million
277,301 New
277,301 $1.85 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $276M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.